Search results for "pause"

showing 10 items of 467 documents

Effect of 2 years of endurance and high-impact training on preventing osteoporosis in postmenopausal women: randomized clinical trial.

2018

The aim of the study was to analyze the effects of endurance and high-impact training oriented toward preventing osteoporosis in postmenopausal women with calcium and vitamin D supplementation.This study was a randomized clinical trial. Thirty-six postmenopausal women were randomized to the control and experimental groups. Thirty-four women completed the 2-year interventions. The control group training involved walking at an intense pace. The experimental group conducted high-impact training specifically oriented to prevent osteoporosis. Dual-energy x-ray absorptiometry was used to estimate the T-scores of the lumbar spine and femoral neck.The fast-walking group showed constant T-scores in …

medicine.medical_specialtyOsteoporosis030209 endocrinology & metabolismWalkinglaw.invention03 medical and health sciences0302 clinical medicineAbsorptiometry PhotonRandomized controlled triallawBone DensitymedicineVitamin D and neurologyHumansVitamin DOsteoporosis PostmenopausalPostmenopausal womenLumbar VertebraeBone Density Conservation Agentsbusiness.industryFemur NeckObstetrics and GynecologyMiddle Agedmedicine.diseaseCalcium DietaryPostmenopauseEndurance TrainingPhysical therapyFemalebusiness030217 neurology & neurosurgeryMenopause (New York, N.Y.)
researchProduct

Risk of Parkinson disease in women: Effect of reproductive characteristics

2004

Objective: To investigate the association between some fertile life characteristics and Parkinson disease (PD) in women. Methods: Women affected by PD and control subjects were matched one to one by age (±2 years). One hundred thirty-one women with idiopathic PD and 131 matched control subjects were interviewed. Controls were randomly selected from the resident list of the same municipality of residence of cases. All subjects had a Mini-Mental State Examination score of ≥24. Cumulative length of pregnancies, age at menarche, age and type of menopause, and estrogen use before and after menopause were investigated in cases and controls through a structured questionnaire. Models of matched pai…

medicine.medical_specialtyOvariectomySurgical MenopauseRisk FactorsSurveys and QuestionnairesmedicineHumansAge of OnsetReproductive HistoryAgedMenarcheUnivariate analysisLife lengthbusiness.industryObstetricsEstrogen Replacement TherapyCase-control studyEstrogensParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseSurgeryMenopauseParityItalyCase-Control StudiesMenarcheFemaleNeurology (clinical)MenopauseAge of onsetbusiness
researchProduct

Cardiovascular risk and events in polycystic ovary syndrome

2009

Young women with polycystic ovary syndrome (PCOS) present a high risk for cardiovascular disease because of the presence of abdominal obesity, insulin resistance and androgen excess. In addition, they present with endothelial dysfunction and early signs of atherosclerosis (increased carotid intima-media thickness and increased coronary calcium). However, the evidence of increased cardiovascular events during the postmenopausal age is relatively small, although some recent studies have indicated a slight increase in the severity of cardiovascular disease in women who had PCOS during their fertile age. The discrepancy between cardiovascular risk in young age and postmenopausal cardiovascular …

medicine.medical_specialtyPCOS Cardiovascular risk myocardial infarction stroke atherosclerosisSettore MED/09 - Medicina InternaDiseaseAndrogen ExcessSeverity of Illness IndexSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsInternal medicinePrevalencemedicineHumansEndothelial dysfunctionAbdominal obesityEvidence-Based Medicinebusiness.industryHyperandrogenismObstetrics and GynecologyGeneral Medicinemedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareSettore MED/40 - Ginecologia E OstetriciaPolycystic ovaryPostmenopauseEndocrinologyPremenopauseCardiovascular DiseasesFemalemedicine.symptombusinessDyslipidemiaPolycystic Ovary SyndromeClimacteric
researchProduct

The new frontier of bone formation: a breakthrough in postmenopausal osteoporosis?

2009

Osteoporosis is a chronic disease that accelerates after menopause in many women. Most of the pharmacologic attempts to control the disease, such as hormone therapy, have emphasized the constraint of bone resorption. Since recent years have witnessed important advances in the field of bone formation, this review aims to update the present knowledge on the mechanisms affecting osteoblastogenesis and on the therapeutic results achieved by recently approved drugs.We sought peer-reviewed, full-length basic and clinical articles published between 1995 and May 2008 using a PubMed search strategy, with the terms osteoporosis and osteoblast, osteoporosis and strontium ranelate, and osteoporosis and…

medicine.medical_specialtyPediatricsmedicine.medical_treatmentOsteoporosisThiophenesDiseasePostmenopausal osteoporosisFractures BoneStrontium ranelateOsteogenesisOrganometallic CompoundsmedicineAnimalsHumansBone formationOsteoporosis PostmenopausalAgedOsteoblastsBone Density Conservation Agentsbusiness.industryObstetrics and GynecologyCell DifferentiationGeneral MedicineMiddle Agedmedicine.diseaseSurgeryMenopauseChronic diseaseGene Expression RegulationParathyroid HormoneFemaleHormone therapybusinessmedicine.drugClimacteric
researchProduct

The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention

2005

Hormone replacement therapy (HRT) has been reported to exert a positive effect on preserving muscle strength following the menopause, however, the mechanism of action remains unclear. We examined whether the mechanism involved preservation of muscle composition as determined by skeletal muscle attenuation. Eighty women aged 50-57 years were randomly assigned to either: HRT, exercise (Ex), HRT + exercise (ExHRT), and control (Co) for 1 year. The study was double-blinded with subjects receiving oestradiol and norethisterone acetate (Kliogest) or placebo. Exercise included progressive high-impact training for the lower limbs. Skeletal muscle attenuation in Hounsfield units (HU) was determined …

medicine.medical_specialtyPhysiologymedia_common.quotation_subjectAdipose tissuePhysical exerciseVertical jumpDouble-Blind MethodPhysiology (medical)Internal medicinemedicineHormone replacement therapy (male-to-female)Body SizeHumansMuscle SkeletalExerciseMenstrual cyclemedia_commonAnalysis of Variancebusiness.industryBody WeightEstrogen Replacement TherapySkeletal muscleGeneral MedicineMiddle Agedmedicine.diseaseNorethisterone acetatePostmenopauseMenopauseEndocrinologymedicine.anatomical_structureAdipose TissueFemaleTomography X-Ray Computedbusinessmedicine.drugClinical Physiology and Functional Imaging
researchProduct

Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female tw…

2009

Estrogen concentration has been suggested to play a role in tendon abnormalities and injury. In physically active postmenopausal women, hormone replacement therapy (HRT) has been suggested to decrease tendon diameter. We hypothesized that HRT use and physical activity are associated with Achilles tendon size and tissue structure. The study applied cotwin analysis of fourteen 54- to 62-yr-old identical female twin pairs with current discordance for HRT use for an average of 7 yr. Achilles tendon thickness and cross-sectional areas were determined by ultrasonography, and tendon structural organization was analyzed from the images using linear discriminant analysis (LDA). Maximal voluntary and…

medicine.medical_specialtyPhysiologymedicine.drug_classEstroneHormone Replacement TherapyAnterior cruciate ligamentPhysical activityMonozygotic twinPhysical exerciseMotor ActivityAchilles Tendon03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineSex Hormone-Binding GlobulinMedicineHumansTestosteroneMuscle StrengthAgedUltrasonographyAchilles tendonbusiness.industryEstrogens030229 sport sciencesTwins MonozygoticMiddle AgedTendonmedicine.anatomical_structureEndocrinologyCholesterolTransgender hormone therapyEstrogenFemaleMenopausebusiness030217 neurology & neurosurgeryMuscle ContractionJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct

Early, but not late onset estrogen replacement therapy prevents oxidative stress and metabolic alterations caused by ovariectomy.

2014

Aims: The usefulness of estrogen replacement therapy (ERT) in preventing oxidative stress associated with menopause is controversial. We aimed to study if there is a critical time window for effective treatment of the effects of ovariectomy with estrogens at the molecular, metabolic, and cellular level. Results: Our main finding is that early, but not late onset of ERT prevents an ovariectomy-associated increase in mitochondrial hydrogen peroxide levels, oxidative damage to lipids and proteins, and a decrease in glutathione peroxidase and catalase activity in rats. This may be due to a change in the estrogen receptor (ER) expression profile: ovariectomy increases the ER α/β ratio and immedi…

medicine.medical_specialtyPhysiologymedicine.drug_classGlucose uptakeOvariectomyClinical BiochemistryGlucose Transport Proteins FacilitativeEstrogen receptorMitochondria LiverBiologymedicine.disease_causeBiochemistryAntioxidantsInternal medicinemedicineAnimalsMetabolomicsMolecular BiologyGeneral Environmental Sciencechemistry.chemical_classificationEstradiolGlutathione peroxidaseEstrogen Replacement TherapyGlucose transporterBrainCell BiologyHydrogen Peroxidemedicine.diseaseRatsMenopauseOxidative StressOriginal Research CommunicationsEndocrinologyGlucosechemistryEstrogenCatalasebiology.proteinGeneral Earth and Planetary SciencesFemaleOxidative stressAntioxidantsredox signaling
researchProduct

Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled…

2001

An age-related decline in muscle performance is a known risk factor for falling, fracture and disability. In women, a clear deterioration is observed from early menopause. The effect of hormone replacement therapy (HRT) in preserving muscle performance is, however, unclear. This trial examined the effects of a 12-month HRT and high-impact physical exercise regimen on skeletal muscle in women in early menopause. A total of 80 women aged 50–57 years were assigned randomly to one of four groups: exercise (Ex), HRT, exercise+HRT (ExHRT) and control (Co). The exercise groups participated in a high-impact training programme. The administration of HRT (oestradiol/noretisterone acetate) or placebo …

medicine.medical_specialtyPlacebo-controlled studyPhysical exercisePlacebolaw.inventionDouble-Blind MethodRandomized controlled triallawInternal medicineElectric ImpedancemedicineHumansExercise physiologyMuscle SkeletalExerciseAnalysis of VarianceEstradiolbusiness.industryEstrogen Replacement TherapySkeletal muscleGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyBiomechanical PhenomenaPostmenopauseMenopausemedicine.anatomical_structureEndocrinologyTorqueAnesthesiaBody CompositionFemaleNorethindronemedicine.symptomTomography X-Ray ComputedbusinessMuscle contractionClinical Science
researchProduct

Determinants of arterial stiffness in pre- and postmenopausal women

2013

medicine.medical_specialtyPostmenopausal womenbusiness.industrymedia_common.quotation_subjectmedicine.diseaseMenopauseMICROBIOLOGY PROCEDURESGonadal Steroid HormonesInternal medicinemedicineMenarcheArterial stiffnessCardiologyCardiology and Cardiovascular MedicinebusinessBreast feedingMenstrual cyclemedia_commonEuropean Heart Journal
researchProduct

Reduced corneal thickness values in postmenopausal women with dry eye.

2004

To study and compare the corneal thickness values of postmenopausal women with dry eye and postmenopausal women without dry eye.The corneal thickness value of 30 postmenopausal women with dry eye (dry eye group; aged 52 to 55 years) and 32 postmenopausal women without dry eye (normal group; aged 51 to 55 years) was analyzed with the Orbscan Topography System II. Each woman underwent a tear breakup test, the Schirmer test, fluorescein staining of the cornea, and an analysis of the meibomian gland by slit lamp before corneal thickness measurement. The statistical analysis was performed by means of the unpaired Student t test.The mean corneal thickness value was significantly decreased in post…

medicine.medical_specialtyPostmenopausal womengenetic structuresbusiness.industryCorneal TopographyMeibomian GlandsMiddle Agedeye diseasesSurgeryCorneaPostmenopauseOphthalmologyOphthalmologyTearsMedicineHumansBody Weights and MeasuresDry Eye SyndromesFemalesense organsProspective StudiesbusinessCornea
researchProduct